Autoimmune Inflammatory Myopathy After Treatment With Ipilimumab

Can J Neurol Sci. 2009 Jul;36(4):518-20. doi: 10.1017/s0317167100007939.

Publication types

  • Case Reports

MeSH terms

  • Antibodies, Monoclonal / adverse effects*
  • Antibodies, Monoclonal / therapeutic use*
  • Antigens, CD / immunology*
  • Autoimmune Diseases / diagnosis
  • Autoimmune Diseases / etiology*
  • CTLA-4 Antigen
  • Female
  • Humans
  • Ipilimumab
  • Melanoma / drug therapy*
  • Middle Aged
  • Myositis / chemically induced*

Substances

  • Antibodies, Monoclonal
  • Antigens, CD
  • CTLA-4 Antigen
  • CTLA4 protein, human
  • Ipilimumab